Paolo Marcucci

Kedrion SpA is a holding company, which engages in the production and distribution of plasma-derived therapeutic products for the treatment of hemophilia and immune system deficiencies. It offers standard intravenous immunoglobulin, human albumin solution, human rabies immunoglobulin, prothrombin complex concentrate, and fibrin sealant. Its products include Kedrab, Gammaked, Uman Complex, Kolfib, and Uman Albumin. The company was founded by Guelfo Marcucci in 2001 and is headquartered in Barga, Italy.

Kedrion Biopharma, Inc. operates as an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Its services include Italian partnership, contract manufacturing, technology transfer, and biological safety center. The company was founded in 2011 and is headquartered in Fort Lee, NJ.